Skip to content

Nkx6 2 Related Disorder Cn381060

Published: July 22, 2026Updated: August 20, 2026

A genetic neurological disorder caused by mutations affecting brain development. It typically appears in early childhood with severe developmental delays, and treatment centers on supportive therapies and multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Refractory seizures

!

Optic atrophy

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(neurologic)

Progressive spasticity

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive early intervention therapy

Early childhood physical therapy focusing on gross motor development, muscle tone management, and prevention of secondary musculoskeletal complications.

physical_therapy
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Botulinum toxin injections for spasticity

Local injection of botulinum toxin to manage severe spasticity affecting mobility, positioning, and comfort in upper and lower extremities.

procedure

Additional treatment options

Dysphagia management and nutritional support

Assessment and management of swallowing difficulties with appropriate food texture modifications and feeding assistance to maintain adequate nutrition.

dietary

Developmental and behavioral support

Early intervention psychological services addressing cognitive development, behavioral regulation, and family education about the disorder.

psychological

Multisystem surveillance program

Comprehensive monitoring for associated complications including respiratory issues, seizures, and endocrine abnormalities that may accompany NKX6-2 related disorders.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Nkx6 2 Related Disorder Cn381060?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Nkx6 2 Related Disorder Cn381060. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy